(CIDRAP News) – Some professional groups and scientists think it's a good idea to classify highly pathogenic avian (HPAI) H5N1 influenza viruses as "select agents" requiring special research precautions, while others say the step is unnecessary and would impede research, according to comments they have filed with the US Department of Health and Human Services (HHS).
(CIDRAP News) – Federal health officials are in the midst of crafting a framework for funding H5N1 avian influenza gain-of-function studies, and today at a workshop they heard varied feedback from researchers, biosecurity experts, and others.
(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.
(CIDRAP News) – News reports about possible airflow problems at the US Centers for Disease Control and Prevention (CDC) biosafety level 3 (BSL-3) lab in Atlanta are fueling perceptions that the agency isn't following its own rules, but the reported conditions at the lab don't appear to have posed a public health threat, according to some expert observers.
(CIDRAP News) – The World Health Organization (WHO) hopes to hold a meeting late this fall to discuss "dual-use" research issues raised in the controversy over publication of two studies involving lab-modified H5N1 viruses with increased transmissibility, a WHO official said today.
(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.
(CIDRAP News) – The US National Science Advisory Board for Biosecurity (NSABB) says in a new report that one of two controversial H5N1 avian flu studies needs some clarifications before publication and that some additional information the board heard from the lead author should not be included in the paper.
(CIDRAP News) – A federal advisory board's reversal on publishing two controversial H5N1 studies is poised to shift discussions on the topic that continue in London this week, as more participants in the debate weigh in following the Mar 30 announcement.